SLC7A11 and cancer: The CD44v8–10 stabilizes xCT, an essential component of the cellular antioxidant defense system, thereby allowing cancer stem cells to mitigate oxidative stress, confer ferroptosis resistance, and maintain their tumorigenic capacity [30].